Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Jordi Pou"'
Autor:
John Trowsdale, Aura Muntasell, Des C. Jones, Miguel López-Botet, Jordi Pou, Diogo Baía, Ofer Mandelboim
Publikováno v:
European Journal of Immunology. 46:1681-1690
Leukocyte immunoglobulin-like receptor subfamily B member 1 (LILRB1) has been reported to interact with a wide spectrum of HLA class I (HLA-I) molecules, albeit with different affinities determined by allelic polymorphisms and conformational features
Autor:
Ana I, Curcoy Barcenilla, Victoria, Trenchs Sainz de la Maza, Julia, Herrero Fernández, María, Hernández García, Isabel, Torrús López, Jordi, Pou Fernández, Carles, Luaces Cubells
Publikováno v:
Revista espanola de salud publica. 92
Unintentional injuries are the leading cause of child morbidity and mortality, Emergency Services can be a good place to influence their prevention, guiding and anticipating risk situations. The objective of this work was to determine the knowledge a
Autor:
Ana Isabel Curcoy, Jordi Pou, Victoria Trenchs, Carles Luaces, Diana Rodà, Anibal Dolores Martínez
Publikováno v:
Pediatric Emergency Care.
Objectives The aim of this study is to determine the prevalence and characteristics of fractures in young infants attended at the pediatric emergency department (PED). Methods This is a retrospective study for 2 years (2011-2012) of children younger
Autor:
Jordi Pou, Juan C. Laguna, Cristina Rodríguez, Ricardo Rodríguez-Calvo, Alba Rebollo, Paula Martín-Fuentes, Marta Alegret, Fernando Civeira, José Martínez-González, Ana Cenarro
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1811:556-563
Type II interleukin-1 receptor (IL-1R2) is a non-signaling decoy receptor that negatively regulates the activity of interleukin-1 (IL-1), a pro-inflammatory cytokine involved in atherogenesis. In this article we assessed the relevance of IL-1R2 in at
Autor:
Montserrat Cofán, Marta Alegret, Jordi Pou, Emilio Ros, Juan Carlos Aguna, Gemma Llaverias, Daniel Zambón
Publikováno v:
Clínica e Investigación en Arteriosclerosis. 20:135-144
Introduccion y objetivo La hiperlipemia familiar combinada (HFC) es la hiperlipemia genetica mas comun, y una causa frecuente de enfermedad cardiovascular prematura. Sin embargo, el origen genetico de esta enfermedad todavia no se conoce totalmente.
Publikováno v:
Aging Health. 4:171-180
Alzheimer’s disease (AD), the most common form of dementia, is a major health problem with increasing prevalence associated with the increase in life span. Unfortunately, drugs currently used to treat this disorder have only modest therapeutic effi
Publikováno v:
Clínica e Investigación en Arteriosclerosis. 19:157-165
El ritonavir es uno de los inhibidores de las proteasas que se utilizan como parte del tratamiento antirretroviral de gran actividad (TARGA) para la infeccion por el virus de la inmunodeficiencia humana, y su uso se ha asociado a un aumento en el rie
Publikováno v:
Clínica e Investigación en Arteriosclerosis. 19:92-108
Monocitos y macrofagos son celulas que desempenan un papel clave en todas las etapas del desarrollo de la aterosclerosis. Uno de los fenomenos iniciales en este proceso es la union de monocitos circulantes al endotelio arterial mediante las moleculas
Publikováno v:
Pediatric Neurosurgery. 43:352-357
Objective: To analyze our institution’s work-up for patients with a diagnosis of subdural haematoma (SDH) in order to determine how many of them are secondary to child abuse, as well as to examine their final functional outcome. Methods: Retrospect
Autor:
Martí Iriondo, Teresa Juncosa, Miquel Borràs, Laia Alsina-Manrique, Rafael Jiménez, Carmen Muñoz-Almagro, Jordi Pou
Publikováno v:
Enfermedades Infecciosas y Microbiología Clínica. 24:505-508
Protocols for the prevention of group B streptococcal disease are being widely used with proven efficacy. The aim of this study was to assess compliance with a culture-based approach recommending universal culture screening at 35-37 weeks' gestation,